“Long-term Safety and Efficacy of Difelikefalin in Subjects With Chronic Kidney Disease–Associated Pruritus: Analysis From KALM-1 and KALM-2” (2021) SKIN The Journal of Cutaneous Medicine, 5(6), p. s75. doi:10.25251/skin.5.supp.75.